FR2262965B1 - - Google Patents

Info

Publication number
FR2262965B1
FR2262965B1 FR7407469A FR7407469A FR2262965B1 FR 2262965 B1 FR2262965 B1 FR 2262965B1 FR 7407469 A FR7407469 A FR 7407469A FR 7407469 A FR7407469 A FR 7407469A FR 2262965 B1 FR2262965 B1 FR 2262965B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7407469A
Other languages
French (fr)
Other versions
FR2262965A1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Synthelabo SA
Original Assignee
Delalande SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Delalande SA filed Critical Delalande SA
Priority to FR7407469A priority Critical patent/FR2262965A1/fr
Publication of FR2262965A1 publication Critical patent/FR2262965A1/fr
Application granted granted Critical
Publication of FR2262965B1 publication Critical patent/FR2262965B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7407469A 1974-03-05 1974-03-05 Beta-(4-amino-6-methylpyrimidin-5-yl)propionic acid derivs - with antiulcer, bronchodilator, anticholinergic, hypotensive, diuretic and vasodilator activity Granted FR2262965A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR7407469A FR2262965A1 (en) 1974-03-05 1974-03-05 Beta-(4-amino-6-methylpyrimidin-5-yl)propionic acid derivs - with antiulcer, bronchodilator, anticholinergic, hypotensive, diuretic and vasodilator activity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7407469A FR2262965A1 (en) 1974-03-05 1974-03-05 Beta-(4-amino-6-methylpyrimidin-5-yl)propionic acid derivs - with antiulcer, bronchodilator, anticholinergic, hypotensive, diuretic and vasodilator activity

Publications (2)

Publication Number Publication Date
FR2262965A1 FR2262965A1 (en) 1975-10-03
FR2262965B1 true FR2262965B1 (enExample) 1977-11-04

Family

ID=9135864

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7407469A Granted FR2262965A1 (en) 1974-03-05 1974-03-05 Beta-(4-amino-6-methylpyrimidin-5-yl)propionic acid derivs - with antiulcer, bronchodilator, anticholinergic, hypotensive, diuretic and vasodilator activity

Country Status (1)

Country Link
FR (1) FR2262965A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1192287B (it) * 1977-11-14 1988-03-31 Fujisawa Pharmaceutical Co Derivati di acido cefalosporanico ad azione farmaceutica e relativo procedimento di preparazione

Also Published As

Publication number Publication date
FR2262965A1 (en) 1975-10-03

Similar Documents

Publication Publication Date Title
DE2411539C3 (enExample)
FI750573A7 (enExample)
FR2262965B1 (enExample)
DK1775A (enExample)
AU495920B2 (enExample)
AU495028B2 (enExample)
CS175701B1 (enExample)
AU7253374A (enExample)
CS162515B1 (enExample)
BG20151A1 (enExample)
BG20028A1 (enExample)
AU479768A (enExample)
DD116882A1 (enExample)
CH599917A5 (enExample)
CH597814A5 (enExample)
CH597311A5 (enExample)
CH585804A5 (enExample)
BG20446A1 (enExample)
BG20432A1 (enExample)
AU480187A (enExample)
AU482307A (enExample)
AU482294A (enExample)
AU481765A (enExample)
BG20160A1 (enExample)
BG19870A1 (enExample)

Legal Events

Date Code Title Description
ST Notification of lapse